Table 1.
Clinical Parameters | Patients (n = 519) | Females/Males | |
---|---|---|---|
Sex | Females | 134 | |
Males | 374 | ||
Undeclared | 11 | ||
Age | Median, range | 61, 19–90 | |
Median, range males | 59, 19–88 | ||
Median, range females | 64.5, 24–90 | ||
Undeclared | 11 | ||
Clinical stage | 1 | 20 | 9/11 |
2 | 98 | 33/65 | |
3 | 101 | 26/75 | |
4 | 275 | 64/211 | |
Unknown | 25 | ||
Clinical TNM | T1N0M0 | 18 | 7/11 |
T1N1M0 | 5 | 2/3 | |
T1N2M0 | 7 | 1/6 | |
T1N2M1 | 1 | -/1 | |
T1NxM0 | 2 | 2/- | |
T1N0M0 | 96 | 33/63 | |
T1N0Mx | 1 | -/1 | |
T2N1M0 | 12 | 3/9 | |
T2N1Mx | 1 | 1/- | |
T2N2M0 | 33 | 6/27 | |
T2N2M1 | 1 | -/1 | |
T2N2Mx | 3 | -/3 | |
T1N3M0 | 1 | -/1 | |
T2NxM0 | 1 | -/1 | |
T3N0M0 | 58 | 15/43 | |
T3N0Mx | 1 | 1/- | |
T2N1M0 | 20 | 4/16 | |
T3N1M1 | 1 | 1/- | |
T3N2M0 | 46 | 8/38 | |
T3N2M1 | 1 | 1/- | |
T3N2Mx | 1 | -/1 | |
T3N3M0 | 1 | -/1 | |
T3NxM0 | 2 | -/2 | |
T4N0M0 | 66 | 17/49 | |
T4N0Mx | 1 | 1/- | |
T4N1M0 | 39 | 13/26 | |
T4N2M0 | 62 | 14/48 | |
T4N2Mx | 1 | -/1 | |
T4N3M0 | 7 | 2/5 | |
T4NxM0 | 3 | -/3 | |
TxN1M0 | 1 | -/1 | |
TxN2M0 | 1 | -/1 | |
TxNxMx | 9 | -/9 | |
Unknown | 16 | ||
Smoking history | Smoker | 174 | 35/139 |
Reformed smoker <15 years | 134 | 26/108 | |
Reformed smoker >15 years | 72 | 19/53 | |
Reformed, unknown years | 2 | 0/2 | |
Lifelong non-smoker | 114 | 49/65 | |
Unknown | 23 | ||
Anatomic neoplasm subdivision | Alveolar ridge | 18 | |
Base of tongue | 27 | ||
Buccal mucosa | 20 | ||
Floor of mouth | 60 | ||
Hard palate | 7 | ||
Hypopharynx | 9 | ||
Larynx | 114 | ||
Lip | 3 | ||
Oral cavity | 71 | ||
Oral tongue | 127 | ||
Oropharynx | 10 | ||
Tonsil | 42 | ||
Unknown | 11 | ||
HPV | Positive | 72 | |
Negative | 37 | ||
Unknown | 410 |